News | May 10, 2007

Study Finds Blood Glucose Measurement By Noninvasive Monitor Just Like Lab Analysis

May 11, 2007 - Biosign Technologies Inc., a medical technology company, announced the results of a study showing that blood glucose measurements from its noninvasive monitoring system are not significantly different from laboratory blood analysis.

"The results demonstrate that Biosign's UFIT health monitoring system could also monitor blood glucose, along with heart rate and blood pressure," said Dr. Radu Leca, president and chief technology officer, Biosign. "Our goal is to provide a robust, integrated health monitoring system that can provide valuable information for all parties concerned — patients, physicians, pharmacists, insurers and pharmaceutical companies — with the ability to access this information online in real time."

UFIT, which uses a noninvasive, Web-enabled device that straps around a patient's wrist, responds to the need for an easy-to-use self-monitoring system that reliably and simultaneously captures key data on heart and blood, including heart rate, blood pressure, blood oxygen and blood glucose. The system is intended to optimize the management of chronic diseases such as high blood pressure, heart disease and diabetes.

The study's findings were presented on May 4th at the Institute of Electrical and Electronics Engineers (IEEE) International Workshop on Medical Measurements and Applications (MeMeA). In a separate development at the workshop, the Group for the Standardization of Blood Pressure Measurement, a working group of the IEEE, met to review its progress in advancing the engineering-based standard for automated blood pressure measurement.

The developments at the MeMeA workshop represent important steps in enabling UFIT to comprehensively serve the multibillion dollar personal health monitoring market. Ninety percent of chronic disease management takes place in the home.

About the Glucometry Results in the GAMUT-1 Study

This Biosign-sponsored study assumed that the arterial pulse, a rich source of clinically relevant information (e.g., rate, rhythm, pattern, pressure and oxygen), could also provide information on blood glucose.

The study gathered glucose measurements from 120 participants with blood glucose levels ranging between 3.5 and 27.4 mmol/L.

The results show a tight statistical correlation (0.998, Pearson substantial equivalence) between UFIT and laboratory analysis of blood glucose, with a low (1.63 percent) average of the mean percent difference between the UFIT measurements and the laboratory analysis. The correlation was obtained post-hoc by comparing a feature extracted from the radial artery pulse with laboratory blood glucose data. The methodology resembles that used to correlate HbA1C with the direct measurements of glucose in drawn blood.

For more information call Richard Potts, Biosign Chairman & CEO, at (416) 218-9800 ext. 234, or email him at [email protected].

Related Content

iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
High-Strength MRI May Release Mercury from Amalgam Dental Fillings
News | Magnetic Resonance Imaging (MRI) | July 05, 2018
Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in...
Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning.

Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning. (Images courtesy of Metrasens)

Feature | Magnetic Resonance Imaging (MRI) | July 03, 2018 | By Tobias Gilk
Nearly every job in the country is subject to certain health and safety regulations. Construction workers must wear...
Technology | Magnetic Resonance Imaging (MRI) | June 27, 2018
June 27, 2018 — Zetta Medical Technologies announced the release of Zoom, its latest...
Children with Kidney Disease Show Blood Flow Changes in Brain
News | Neuro Imaging | June 25, 2018
Blood flow changes in the brains of children, adolescents and young adults with chronic kidney disease may explain why...
Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Reduced hippocampal volume on MRI

This figure shows reduced hippocampal volume over the course of 6 years as seen on progressive volumetric analysis and also coronal MRI evaluations (arrows).Progressive volume loss in the mesial temporal lobe on MRI is a characteristic imaging feature of AD. This patient was a case of Alzheimer’s Dementia.

 

News | Neuro Imaging | June 12, 2018
According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
Overlay Init